Cancer Letters
Volume 228, Issue 1 , Pages 21-27, 18 October 2005

MDM2 as MYCN transcriptional target: Implications for neuroblastoma pathogenesis

  • Andrew Slack

      Affiliations

    • Department of Pediatrics, Texas Children's Cancer Center and Center for Cell and Gene Therapy, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    • ,
  • Guillermina Lozano

      Affiliations

    • Department of Molecular Genetics, Section of Cancer Genetics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA
    • ,
  • Jason M. Shohet

      Affiliations

    • Department of Pediatrics, Texas Children's Cancer Center and Center for Cell and Gene Therapy, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    • Corresponding Author InformationCorresponding author. Tel.: +31 20 5666592.

Received 15 December 2004; accepted 12 January 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(05)00350-2

doi:10.1016/j.canlet.2005.01.050

Cancer Letters
Volume 228, Issue 1 , Pages 21-27, 18 October 2005

Article Tools

* Image Usage & Resolution